Etizolam Use Disorder and Withdrawal in a Patient in Sustained Remission From Opioid, Cocaine, and Methamphetamine Use Disorders

Alëna A. Balasanova, MD^b; Benjamin E. Johnson, MD, MS^a

Prim Care Companion CNS Disord 2022;24(2):21cr03043

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (12)

Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addiction. 1989; 89:1353–1357. PubMed CrossRef
World Health Organization and WHO Expert Committee on Drug Dependence. WHO Expert Committee on Drug Dependence: Thirty-Ninth Report. World Health Organization website. License: CC BY-NC-SA 3.0 IG. 2018. Accessed February 28, 2022. https://apps.who.int/iris/handle/10665/260546
Fracasso C, Confalonieri S, Garattini S, et al. Single and multiple dose pharmacokinetics of etizolam in healthy subjects. Eur J Clin Pharmacol. 1991;40(2):181–185. PubMed
Araki K, Yasui-Furukori N, Fukasawa T, et al. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism. Eur J Clin Pharmacol. 2004;60(6):427–430. PubMed CrossRef
Fukasawa T, Yasui-Furukori N, Suzuki A, et al. Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity. Eur J Clin Pharmacol. 2005;61(11):791–795. PubMed CrossRef
Nishii S, Hori H, Kishimoto T, et al. A successful case of dose reduction in etizolam dependence using fine granules: a case report. Int Med Case Rep J. 2014;7:121–122. PubMed
Nakamae T, Shinozuka T, Sasaki C, et al. Case report: etizolam and its major metabolites in two unnatural death cases. Forensic Sci Int. 2008;182(1-3):e1–e6. PubMed CrossRef
O’Connell CW, Sadler CA, Tolia VM, et al. Overdose of etizolam: the abuse and rise of a benzodiazepine analog. Ann Emerg Med. 2015;65(4):465–466. PubMed CrossRef
Shapiro AP, Krew TS, Vazirian M, et al. Novel ways to acquire designer benzodiazepines: a case report and discussion of the changing role of the internet. Psychosomatics. 2019;60(6):625–629. PubMed CrossRef
Carpenter JE, Murray BP, Dunkley C, et al. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017. Clin Toxicol (Phila). 2019;57(4):282–286. PubMed CrossRef
US Drug Enforcement Administration, Diversion Control Division. National Forensic Laboratory Information System: NFLISDrug 2018 Annual Report. Springfield, VA: US Drug Enforcement Administration; 2019.
Aldridge J, Décary-Hétu D. Hidden wholesale: the drug diffusing capacity of online drug cryptomarkets. Int J Drug Policy. 2016;35:7–15. PubMed CrossRef